Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

458
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
458
Schizophrenia01:17

Schizophrenia

673
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
673
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

773
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
773
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

436
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
436

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost.

Neuropsychiatric disease and treatment·2026
Same author

What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?

Schizophrenia (Heidelberg, Germany)·2025
Same author

Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia.

Healthcare (Basel, Switzerland)·2024
Same author

Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study.

Medicina (Kaunas, Lithuania)·2024
Same author

Machine Learning Models for Prediction of Sex Based on Lumbar Vertebral Morphometry.

Diagnostics (Basel, Switzerland)·2023
Same author

Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania.

Healthcare (Basel, Switzerland)·2022

Related Experiment Video

Updated: Jan 7, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

723

Trends in Sudden Death Among Schizophrenia Inpatients.

Andreea-Violeta Popa1,2, Petru Iulian Ifteni1,2, Paula Simina Petric1,2

  • 1Faculty of Medicine, Transilvania University of Brasov, 500036 Brasov, Romania.

Medicina (Kaunas, Lithuania)
|December 31, 2025
PubMed
Summary
This summary is machine-generated.

Sudden unexpected death in schizophrenia inpatients significantly decreased from 2014-2024. Improved care and second-generation antipsychotics likely contributed to this decline, though cardiovascular disease remains a key factor.

Keywords:
antipsychotic agentsautopsycardiovascular diseasescause of deathforensic medicineinpatient mortalitypsychiatric hospitalsrisk factorsschizophreniasudden death

More Related Videos

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.1K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

723
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.1K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.3K

Area of Science:

  • Psychiatry
  • Cardiology
  • Forensic Medicine

Background:

  • Schizophrenia significantly reduces life expectancy, with cardiovascular disease as the primary cause of premature death.
  • Sudden unexpected death is a concern in schizophrenia patients, often linked to heart disease, antipsychotics, and metabolic factors.

Purpose of the Study:

  • To determine the incidence and causes of sudden unexpected death in schizophrenia inpatients from 2014 to 2024.
  • To compare current findings with historical data from the same institution (1989-2013).

Main Methods:

  • Retrospective cohort study of schizophrenia inpatients admitted between January 2014 and December 2024.
  • Review of hospital records and verification of sudden deaths by the Forensic Medicine Service Brașov.
  • Autopsies performed in all cases as per Romanian legislation; sudden death defined as death in asymptomatic patients or within one hour of symptom onset (excluding suicide, homicide, overdose).

Main Results:

  • Six schizophrenia inpatients died suddenly over the 10-year period (mean age 53.2 years).
  • All deceased had long-standing schizophrenia (mean duration 28.7 years) and were on second-generation antipsychotics; three had cardiovascular comorbidity.
  • The incidence of sudden unexpected death declined significantly to 0.27% in 2014-2024, compared to 0.79% in 1989-2013.

Conclusions:

  • A significant decrease in sudden unexpected death incidence among schizophrenia inpatients was observed in the last decade.
  • Improved multidisciplinary care, timely transfer to general hospitals, and increased use of second-generation antipsychotics are potential contributing factors.
  • Cardiovascular disease and airway obstruction remain critical, potentially preventable causes of sudden death in this population.